Hints and tips:
...Disease Control and Prevention] are making it very difficult and putting a lot of requirements on cruise operators to operate out of the US,” said Nigel Thomas, chairman and maritime partner at the law firm Watson...
...Bresch, who joined the company in 1992 as a data-entry clerk, led the group through several multibillion-dollar acquisitions, including takeovers of Sweden’s Meda and the generic drugs business of Abbott Laboratories...
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...Watson Pharmaceuticals and Par Pharmaceutical have previously been prevented from working on a generic film alternative, but Indivior said the latest ruling means they “are now able to pursue their respective...
...Lannett Company, which has a market value of around $700m, dropped 19 per cent while Impax Laboratories (market cap $1.3bn) fell 12.4 per cent....
...The FTC also accused Endo of paying hundreds of millions of dollars in 2012 to Watson Laboratories, now part of Allergan, to delay the introduction of a generic version of Lidoderm, a shingles pain patch...
...Bart Watson, chief economist at the Brewers’ Association, believes tie-ups between craft producers will provide a noble exit for founders who do not want to sell out to the large brewers....
...Abbott Laboratories, the US pharmaceuticals group, has agreed to acquire St Jude Medical for $25bn, in the first mega healthcare deal following a three-month lull after last year’s frantic merger and acquisition...
...In February, Mylan closed a $5.6bn deal to acquire certain non-US assets from Abbott Laboratories....
...In a forest in western Tokyo, Hitachi’s research laboratory is linked to the outside world by a path dubbed the “bridge for geeks”....
...SM began contesting the market for generics last year, introducing the Watsons Generics brand to compete with Unilab and Pascual Laboratories, the second-largest domestic drug manufacturer....
...Rather than funding early-stage research in its own laboratories, Mr Saunders said the company was employing an “open science” approach — buying or licensing drugs that have already been unearthed by smaller...
...Because Watson has the ability to learn, Ross refines its responses based on experience....
...resisted Teva’s advances, preferring instead to pursue its own $33bn hostile bid for Perrigo, a Dublin-based generic drugmaker, just two months after completing a $5.3bn acquisition of products from Abbott Laboratories...
...It bought Watson Pharmaceuticals for $6bn (2012), Ireland-domiciled Warner Chilcott for $9bn (2013) and Forest Laboratories for $25bn (2014)....
Magnus Spence resigns as Dalton CEO and Investec hires Keeran Mane
...So would the new Mylan, which said on Monday that it would invert by purchasing European assets from Abbott Laboratories. The geography is dizzying....
...Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase to date....
...The $25bn purchase of Forest Laboratories, announced on Tuesday, is by far the largest transaction he has overseen so far....
...● Jo Kite has joined Towers Watson as head of the consultant’s pensions and benefits practice in Scotland. Ms Kite, an actuary, was previously at Standard Life....
...Mylan Inc, the US generic drug producer, is eyeing the takeover of Swedish rival Meda in a deal that would create a $23bn-plus pharmaceuticals business as the US healthcare industry goes through one of the...
...FT EVENING ROUND-UP Actavis buys Forest Laboratories for $25bn: “Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase...
...He has set up a company in San Diego called Human Longevity Inc or HLI, which “will build the largest human [DNA] sequencing operation in the world”....
...IBM is investing $1bn to build a business unit around Watson, its “cognitive computing” project....
International Edition